ABIM - Hyponatremia Management

Here are key facts for ABIM from the Acute Hyponatremia Management tutorial, as well as points of interest at the end of this document that are not directly addressed in this tutorial but should help you prepare for the boards. See the tutorial notes for further details and relevant links.

• --

1. Timeline classification: From the time of development section, distinguish between acute hyponatremia (within last 48 hours) and chronic hyponatremia (longer than 48 hours). 2. Neurological manifestations: From the key symptoms section, acute hyponatremia presents with cognitive manifestations (confusion, seizures, coma), motor symptoms (ataxia, tremor), and gastrointestinal symptoms (nausea, vomiting). 3. Physical examination findings: From the key physical exam findings section, assess for peripheral edema from volume overload and cerebral edema with neurological signs of coma. 4. Clinical severity stratification: From the severity section, categorize as severe (<120 mEq/L), moderate (120-130 mEq/L), or mild (130-135 mEq/L). 1. Treatment threshold: From the treatment indication section, intervention is indicated when sodium is <130 mEq/L in acute cases. 2. Correction target: From the general goal section, aim for 5 mEq/L increase over the first few hours while avoiding over-correction over 24 hours. 3. Cerebral edema prevention: From the symptomatic section, for any acutely symptomatic patient, treat rapidly to avoid increased intracranial pressure using a rapid 100 mL 3% hypertonic saline infusion over 10 minutes. 4. Risk-benefit balance: From the general goal section, balance between treating rapidly early to prevent cerebral complications while avoiding osmotic demyelination from over-correction.

• --

1. Symptomatic vs. asymptomatic approach: From the symptomatic and asymptomatic sections, differentiate management based on presence of symptoms - 100 mL 3% saline over 10 minutes for symptomatic patients versus 50 mL 3% saline for asymptomatic patients. 2. Monitoring protocol: From multiple sections, check sodium hourly to ensure appropriate correction rate and adjust therapy accordingly. 3. Autocorrection assessment: From the autocorrecting section, recognize cases already correcting via water diuresis, where no saline bolus is needed - just monitoring targeting a 5 mEq/L increase. 4. Treatment modification indicators: From the autocorrecting section, if sodium drops instead of increases during monitoring of an autocorrecting case, administer the 50 mL 3% saline bolus. 1. Risk factor identification: From the common acute causes section, recognize common scenarios including IV fluid overload in surgery and water intoxication (marathon runners, psychotic polydipsia). 2. Medication review: From the additional management section, identify medications that could be contributing, particularly thiazide diuretics. 3. SIADH consideration: From the additional management section, evaluate for recent surgery, pain, and certain medications as possible causes of SIADH. 4. Treatment principle application: From the general goal section, apply the approach of treating rapidly early, monitoring closely hourly, then leveling off to give the brain a chance to adapt. 1. Additional fluid management: From the additional management section, stop other IV fluids to avoid worsening the hyponatremia. 2. Water restriction: From the additional management section, restrict any electrolyte-free water intake. 3. Underlying etiology investigation: From the additional management section, systematically look for any underlying causes. 4. SIADH-specific interventions: From the additional management section, consider additional treatments (salt tablets, loop diuretics) for SIADH cases. 5. Complication prevention: From the general goal section, focus on avoiding osmotic demyelination through careful monitoring and controlled correction rates.

• --

Below is information not explicitly contained within the tutorial but important for ABIM. 1. Cerebral adaptation mechanisms: Understanding how brain cells adapt to chronic vs. acute changes in serum osmolality. 2. Osmotic demyelination syndrome: Pathophysiology, risk factors, clinical presentation, and management of this complication. 3. Volume status interpretation: Integrating clinical, laboratory, and hemodynamic data to accurately assess volume status. 1. Multiple electrolyte disorders: Management of concurrent hypokalemia, hypophosphatemia, or hypocalcemia with hyponatremia. 2. Beer potomania and tea and toast syndrome: Recognition and specific management considerations. 3. Post-operative hyponatremia: Prevention and management strategies in high-risk surgical patients. 4. Reset osmostat: Diagnostic approach and management implications. 1. Current guidelines: Recent recommendations from professional societies regarding correction rates and monitoring protocols. 2. Novel therapeutic approaches: Emerging therapies for specific etiologies of hyponatremia. 3. Urea as a treatment option: Indications, dosing, and efficacy in specific clinical scenarios. 4. Vasopressin receptor antagonists: Current evidence for their use in hypervolemic and euvolemic hyponatremia.